Summary
- Profile Type
- Business request
- POD Reference
- BRTW20241015002
- Term of Validity
- 15 October 2024 - 15 October 2025
- Company's Country
- Taiwan
- Type of partnership
- Commercial agreement
- Outsourcing agreement
- Supplier agreement
- Targeted Countries
- Denmark
- Italy
- Czechia
- Estonia
- Latvia
- Croatia
- Hungary
- Greece
- Cyprus
- Belgium
- Bulgaria
- Malta
- Luxembourg
- Netherlands
- Slovakia
- Lithuania
- Slovenia
- Portugal
- Poland
- Romania
- Spain
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- The Taiwanese pharmaceutical company is dedicated to the innovation, R&D, manufacturing, and upgrade of services in the pharmaceutical industry. Since its establishment, a variety of advances in the development of generic pharmaceutical and healthcare products for use in humans and animals have been made. It is looking for CMO/CDMO partners or distribution agents.
- Full Description
-
Founded in 1952, the company focuses on generic pharmaceuticals. To explore global generic markets, the company provides niche and high manufacturing complexity API/generic drugs and the 505(b)(2) new drugs to the North American market.
The company has already had commercial relations with USA, Canada, and Japan pharma companies. Currently it has partnerships with ASEAN pharmaceutical companies in Malaysia, Singapore, and Myanmar where they agent and selling the company’s generic medicines for more than 15 years. - Advantages and Innovations
- High and long experience, which allows the company to maintain a relationship of trust with its clients. This company is distinguished by its work and positioning in the market due to the quality of the products, the knowledge and technical and specialized assistance. For this, it has a team of specialists dedicated to formulation development and FDF production. The pharmaceutical manufacturer has six PIC/s GMP-certified plants, four of six are Japan PMDA inspected and one of them is US FDA inspected. Besides, one cGMP-certified manufacturing site for animal medicinal products.
- Technical Specification or Expertise Sought
- The company is seeking cooperation with companies from different sectors of the pharmaceutical industry that need the services and want to cooperate under the manufacturing agreement. The company hopes to be involved in co-developing formulation and to receive orders of manufacturing finished generic products from partners.
- Stage of Development
- Already on the market
- Sustainable Development Goals
- Goal 6: Clean Water and Sanitation
- Goal 17: Partnerships to achieve the Goal
- Goal 12: Responsible Consumption and Production
- Goal 3: Good Health and Well-being
- Goal 8: Decent Work and Economic Growth
- Goal 5: Gender Equality
- Goal 7: Affordable and Clean Energy
- Goal 9: Industry, Innovation and Infrastructure
Partner Sought
- Expected Role of a Partner
- The company is seeking cooperation with companies from different sectors of the Pharmaceutical Industry that need the services and want to cooperate under the manufacturing agreement. The company hopes to be involved in co-developing formulation and to receive orders of manufacturing finished generic products from partners.
- Type and Size of Partner
- SME 50 - 249
- Big company
- Type of partnership
- Commercial agreement
- Outsourcing agreement
- Supplier agreement
Dissemination
- Market keywords
- 05007002 - Pharmaceuticals/fine chemicals
- 05007007 - Other medical/health related (not elsewhere classified)
- 05005022 - Other clinical medicine
- 05005008 - Internal medicine
- Targeted countries
- Denmark
- Italy
- Czechia
- Estonia
- Latvia
- Croatia
- Hungary
- Greece
- Cyprus
- Belgium
- Bulgaria
- Malta
- Luxembourg
- Netherlands
- Slovakia
- Lithuania
- Slovenia
- Portugal
- Poland
- Romania
- Spain